Compile Data Set for Download or QSAR
maximum 50k data
Found 185 of ic50 for UniProtKB: P49137
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605814(US11680056, Example 5 | US11680056, Example 5A | U...)
Affinity DataIC50:  6.31nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605866(US11680056, Example 34B)
Affinity DataIC50:  12.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605738(US11680056, Example 4 | US11680056, Example 4A | U...)
Affinity DataIC50:  15.8nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605814(US11680056, Example 5 | US11680056, Example 5A | U...)
Affinity DataIC50:  15.8nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605732(US11680056, Example 3 | US11680056, Example 3A | U...)
Affinity DataIC50:  20nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605826(US11680056, Example 14)
Affinity DataIC50:  20nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605817(US11680056, Example 6 | US11680056, Example 6A | U...)
Affinity DataIC50:  25.1nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605817(US11680056, Example 6 | US11680056, Example 6A | U...)
Affinity DataIC50:  31.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605731(US11680056, Example 2)
Affinity DataIC50:  31.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605846(US11680056, Example 25A)
Affinity DataIC50:  31.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605840(US11680056, Example 22A | US11680056, Example 22B)
Affinity DataIC50:  31.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605828(US11680056, Example 16)
Affinity DataIC50:  39.8nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605859(US11680056, Example 32A | US11680056, Example 32B ...)
Affinity DataIC50:  63.1nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605850(US11680056, Example 27A | US11680056, Example 27B)
Affinity DataIC50:  63.1nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  79.4nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  158nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605932(US11680056, Example 65A | US11680056, Example 65B)
Affinity DataIC50:  200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605834(US11680056, Example 19A | US11680056, Example 19B)
Affinity DataIC50:  251nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605936(US11680056, Example 67A)
Affinity DataIC50:  316nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605929(US11680056, Example 63B)
Affinity DataIC50:  316nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605920(US11680056, Example 59A | US11680056, Example 59B)
Affinity DataIC50:  316nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605863(US11680056, Example 33A | US11680056, Example 33B)
Affinity DataIC50:  316nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605939(US11680056, Example 68B)
Affinity DataIC50:  398nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605822(US11680056, Example 7)
Affinity DataIC50:  501nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605924(US11680056, Example 61A | US11680056, Example 61B)
Affinity DataIC50:  631nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605856(US11680056, Example 30)
Affinity DataIC50:  631nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605916(US11680056, Example 57A | US11680056, Example 57B)
Affinity DataIC50:  794nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605909(US11680056, Example 53A | US11680056, Example 53B)
Affinity DataIC50:  794nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605926(US11680056, Example 62A)
Affinity DataIC50:  794nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605738(US11680056, Example 4 | US11680056, Example 4A | U...)
Affinity DataIC50:  794nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605935(US11680056, Example 66B)
Affinity DataIC50:  1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605918(US11680056, Example 58A)
Affinity DataIC50:  1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605859(US11680056, Example 32A | US11680056, Example 32B ...)
Affinity DataIC50:  1.00E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605859(US11680056, Example 32A | US11680056, Example 32B ...)
Affinity DataIC50:  1.26E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605911(US11680056, Example 54A | US11680056, Example 54B)
Affinity DataIC50:  1.59E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605844(US11680056, Example 24A | US11680056, Example 24B)
Affinity DataIC50:  1.59E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605825(US11680056, Example 10)
Affinity DataIC50:  1.59E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605848(US11680056, Example 26A | US11680056, Example 26B)
Affinity DataIC50:  1.59E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605914(US11680056, Example 56A | US11680056, Example 56B)
Affinity DataIC50:  1.59E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605848(US11680056, Example 26A | US11680056, Example 26B)
Affinity DataIC50:  2.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605857(US11680056, Example 31A)
Affinity DataIC50:  2.00E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605930(US11680056, Example 64A | US11680056, Example 64B)
Affinity DataIC50:  2.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605836(US11680056, Example 20A | US11680056, Example 20B)
Affinity DataIC50:  2.00E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605814(US11680056, Example 5 | US11680056, Example 5A | U...)
Affinity DataIC50:  2.00E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605867(US11680056, Example 34C)
Affinity DataIC50:  2.00E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605838(US11680056, Example 21A | US11680056, Example 21B)
Affinity DataIC50:  2.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605899(US11680056, Example 48A | US11680056, Example 48B)
Affinity DataIC50:  2.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605895(US11680056, Example 46A | US11680056, Example 46B)
Affinity DataIC50:  2.51E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605877(US11680056, Example 37A | US11680056, Example 37B)
Affinity DataIC50:  2.51E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605817(US11680056, Example 6 | US11680056, Example 6A | U...)
Affinity DataIC50:  2.51E+3nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 185 total ) | Next | Last >>
Jump to: